Osteoporotic Fractures
Also known as: Osteoporotic Fracture / Osteoporosis Fracture / Osteoporosis related fractures / Osteoporotic fracture of bone (disorder) / Osteoporosis with current pathological fracture / Osteoporotic fracture (morphologic abnormality) / Osteoporosis with fracture / Fracture due to osteoporosis
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00017 | Salmon calcitonin | A synthetic peptide form of calcitonin used to inhibit bone resorption in the treatment of hypercalcemia, osteoporosis, and Paget's disease. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB00017 | Salmon calcitonin | Calcitonin receptor | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB06285 | Teriparatide | 2 | Completed | 1 |
| DB06285 | Teriparatide | 2 | Enrolling by Invitation | 1 |
| DB05084 | Abaloparatide | 3 | Completed | 1 |
| DB06643 | Denosumab | 4 | Completed | 1 |
| DB06643 | Denosumab | 4 | Recruiting | 1 |
| DB01592 | Iron | 4 | Recruiting | 1 |
| DB00884 | Risedronic acid | 4 | Unknown Status | 1 |
| DB11866 | Romosozumab | 4 | Not Yet Recruiting | 1 |
| DB11866 | Romosozumab | 4 | Recruiting | 1 |
| DB00399 | Zoledronic acid | 4 | Completed | 2 |
| DB00399 | Zoledronic acid | 4 | Not Yet Recruiting | 1 |
| DB00399 | Zoledronic acid | 4 | Recruiting | 1 |
| DB06643 | Denosumab | Not Available | Completed | 1 |
| DB06643 | Denosumab | Not Available | Not Yet Recruiting | 1 |
| DB06285 | Teriparatide | Not Available | Not Yet Recruiting | 1 |